📣 VC round data is live. Check it out!

MicroPort Valuation Multiples

Discover revenue and EBITDA valuation multiples for MicroPort and similar public comparables like Bausch Health, AddLife, MicroPort Scientific, Fukuda Denshi and more.

MicroPort Overview

About MicroPort

Shanghai Microport Endovascular Medtech Co Ltd is primarily engaged in the development, production and sales of medical devices for aortic and peripheral vascular interventions.


Founded

2012

HQ

China

Employees

N/A

Financials (LTM)

Revenue: $216M
EBITDA: $116M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MicroPort Financials

MicroPort reported last 12-month revenue of $216M and EBITDA of $116M.

In the same LTM period, MicroPort generated $155M in gross profit, $116M in EBITDA, and $90M in net income.

Revenue (LTM)


MicroPort P&L

In the most recent fiscal year, MicroPort reported revenue of $200M and EBITDA of $109M.

MicroPort is profitable as of last fiscal year, with gross margin of 71%, EBITDA margin of 54%, and net margin of 42%.

See analyst estimates for MicroPort
LTMLast FY202320242025202620272028
Revenue$216M$200M$175M$178M$200M
Gross Profit$155M$142M$134M$130M$142M
Gross Margin72%71%76%73%71%
EBITDA$116M$109M$90M$104M$109M
EBITDA Margin54%54%51%58%54%
EBIT Margin47%48%48%47%48%
Net Profit$90M$83M$73M$74M$83M
Net Margin42%42%41%42%42%

Financial data powered by Morningstar, Inc.

MicroPort Stock Performance

MicroPort has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


MicroPort's stock price is $15.44.

MicroPort share price increased by 2.5% in the last 30 days, and by 20.2% in the last year.

MicroPort has an EPS (earnings per share) of $0.68.

See more trading valuation data for MicroPort
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B3.9%2.5%3.7%20.2%$0.68

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MicroPort Valuation Multiples

MicroPort trades at 7.4x EV/Revenue multiple, and 13.8x EV/EBITDA.

See NTM and 2027E valuation multiples for MicroPort

EV / Revenue (LTM)


MicroPort Financial Valuation Multiples

As of June 3, 2026, MicroPort has market cap of $2B and EV of $2B.

MicroPort has a P/E ratio of 21.1x.

LTMLast FY202320242025202620272028
EV/Revenue7.4x8.0x9.1x9.0x8.0x
EV/EBITDA13.8x14.7x17.7x15.4x14.7x
EV/EBIT15.6x16.6x19.2x19.1x16.6x
EV/Gross Profit10.3x11.3x11.9x12.3x11.3x
P/E21.1x22.9x26.1x25.6x22.9x
EV/FCF25.9x40.0x29.4x67.1x40.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MicroPort Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MicroPort Margins & Growth Rates

MicroPort grew revenue by 22% and EBITDA by 18% in the last fiscal year.

In the most recent fiscal year, MicroPort reported gross margin of 71%, EBITDA margin of 54%, and net margin of 42%.

See estimated margins and future growth rates for MicroPort

MicroPort Margins

Last FY202420252026202720282029
Gross Margin71%73%71%72%
EBITDA Margin54%58%54%52%
EBIT Margin48%47%48%47%
Net Margin42%42%42%42%
FCF Margin20%13%20%39%

MicroPort Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth22%2%12%22%
Gross Profit Growth24%(3%)9%24%
EBITDA Growth18%16%4%18%
EBIT Growth19%0%15%19%
Net Profit Growth23%2%12%23%
FCF Growth140%(56%)68%140%

Data powered by FactSet, Inc. and Morningstar, Inc.

MicroPort Operational KPIs

MicroPort's Rule of 40 is 75% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

MicroPort's Rule of X is 108% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for MicroPort
LTMLast FY202320242025202620272028
Rule of 4071%75%---
Bessemer Rule of X97%108%---
S&M Expenses to Revenue15%15%6%6%8%
G&A Expenses to Revenue7%7%2%3%3%
R&D Expenses to Revenue5%5%15%8%5%
Opex to Revenue-23%29%26%23%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

MicroPort Competitors

MicroPort competitors include Bausch Health, AddLife, MicroPort Scientific, Fukuda Denshi, NovoCure, Embla Medical, Oxford Nanopore Technologies, Draegerwerk, Establishment Labs and Mehow Innovative.

Most MicroPort public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Bausch Health2.1x2.1x6.0x5.8x
AddLife2.0x2.0x11.9x12.2x
MicroPort Scientific2.4x2.3x16.6x14.0x
Fukuda Denshi1.8x1.8x6.6x-
NovoCure2.5x2.4x(47.6x)(73.6x)
Embla Medical2.4x2.3x12.0x11.5x
Oxford Nanopore Technologies5.0x4.5x(12.9x)(15.0x)
Draegerwerk0.4x0.4x3.9x3.8x

This data is available for Pro users. Sign up to see all MicroPort competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MicroPort

When was MicroPort founded?MicroPort was founded in 2012.
Where is MicroPort headquartered?MicroPort is headquartered in China.
Is MicroPort publicly listed?Yes, MicroPort is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of MicroPort?MicroPort trades under 688016 ticker.
When did MicroPort go public?MicroPort went public in 2019.
Who are competitors of MicroPort?MicroPort main competitors include Bausch Health, AddLife, MicroPort Scientific, Fukuda Denshi, NovoCure, Embla Medical, Oxford Nanopore Technologies, Draegerwerk, Establishment Labs, Mehow Innovative.
What is the current market cap of MicroPort?MicroPort's current market cap is $2B.
What is the current revenue of MicroPort?MicroPort's last 12 months revenue is $216M.
What is the current revenue growth of MicroPort?MicroPort revenue growth (NTM/LTM) is 17%.
What is the current EV/Revenue multiple of MicroPort?Current revenue multiple of MicroPort is 7.4x.
What is the current EBITDA of MicroPort?MicroPort's last 12 months EBITDA is $116M.
What is MicroPort's EBITDA margin?MicroPort's last 12 months EBITDA margin is 54%.
What is the current EV/EBITDA multiple of MicroPort?Current EBITDA multiple of MicroPort is 13.8x.
What is the current FCF of MicroPort?MicroPort's last 12 months FCF is $62M.
What is MicroPort's FCF margin?MicroPort's last 12 months FCF margin is 29%.
What is the current EV/FCF multiple of MicroPort?Current FCF multiple of MicroPort is 25.9x.
How many companies MicroPort has acquired to date?MicroPort hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies MicroPort has invested to date?MicroPort hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to MicroPort

Lists including MicroPort

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial